Financhill
Back

Bicara Therapeutics Vs. Arcellx Industry Stock Comparison

Sell
28

BCAX
Bicara Therapeutics

Last Price:
$10.77
Seasonality Move:
--
Sell
30

ACLX
Arcellx

Last Price:
$59.16
Seasonality Move:
19.53%
Sell
28
Bicara Therapeutics (BCAX) is a Sell

Is Bicara Therapeutics a Buy, Sell or Hold?

  • The current Bicara Therapeutics [BCAX] share price is $10.77. The Score for BCAX is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
  • BCAX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
30
Arcellx (ACLX) is a Sell

Is Arcellx a Buy, Sell or Hold?

  • The current Arcellx [ACLX] share price is $59.15. The Score for ACLX is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
  • ACLX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

BCAX Stock Price Chart

What is Bicara Therapeutics's stock price today?

  • The Bicara Therapeutics share price today is $10.77
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BCAX is experiencing buying pressure, which is a positive indicator for future bullish movement.

ACLX Stock Price Chart

What is Arcellx's stock price today?

  • The Arcellx share price today is $59.15
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ACLX is experiencing buying pressure, which is a positive indicator for future bullish movement.

BCAX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.85 Sell
Relative Strength Index (14 RSI): 41.71 Sell
Chaikin Money Flow: 268151 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (10.91 - 14.11) Sell
Bollinger Bands (100): (11.72 - 18.2) Sell

ACLX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.99 Sell
Relative Strength Index (14 RSI): 43.04 Sell
Chaikin Money Flow: 472667 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (60.48 - 72.5) Sell
Bollinger Bands (100): (62.55 - 81.55) Sell

BCAX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 10.73 Buy
20-day SMA: 12.15 Sell
50-day SMA: 12.77 Sell
200-day SMA: 0 Buy
8-day EMA: 10.81 Sell
20-day EMA: 11.78 Sell
50-day EMA: 12.87 Sell
200-day EMA: 11.3 Sell

ACLX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 59.19 Sell
20-day SMA: 65.29 Sell
50-day SMA: 65.89 Sell
200-day SMA: 72.76 Sell
8-day EMA: 59.44 Sell
20-day EMA: 63.01 Sell
50-day EMA: 66.4 Sell
200-day EMA: 69.26 Sell

Bicara Therapeutics Earnings Growth & BCAX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.02 per share, and a decrease next year of $0.51 per share.

Arcellx Earnings Growth & ACLX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.52 per share, a decrease next quarter of $0.15 per share, a decrease this year of $1.52 per share, and an increase next year of $0.50 per share.

Bicara Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Arcellx Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):